Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies

NCT00266279 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT00266279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00266279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
Lead sponsor
University of Louisville
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
October 31, 2009
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head or neck cancer